Weekly injections are also commonly used in structured titration plans
Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy), liraglutide (Saxenda), and the newer tirzepatide (Zepbound), have become increasingly prominent in the management of obesity in the United Kingdom
We also delve into the ongoing research along with future prospects of DPP-4 inhibitors, suggesting an increasing role for these agents in applications beyond the management of diabetes
Association of American Medical Colleges
Related guides Zepbound to Wegovy Conversion Chart: The Evidence-Based Dose Translation Guide Providers Actually Use Estradiol Patch Dosage Chart: Every Strength, Equivalent, and Conversion You Need Switching From Wegovy to Zepbound: The Complete Dosage Conversion Chart Switching From Wegovy to Zepbound: The Evidence-Based Transition Protocol and Dose Conversion Guide Switching from Wegovy to Zepbound: The Dose Conversion Protocol That Minimizes Side Effects Switching from Zepbound to Wegovy: The Dose Conversion Protocol, Timeline, and Why the Transition Isn't 1:1 Tool: dosage calculator Sources Wilding JPH et al
